Mounjaro has become one of the most talked-about weight loss medications in the UK, and for good reason. Clinical trials have shown it can produce average weight losses of up to 22.5% of body weight, results that have fundamentally changed what patients and clinicians expect from non-surgical weight management. But if you live in Northern Ireland, the question is not just whether Mounjaro works. It is how you actually get it.
This guide covers everything you need to know about accessing Mounjaro in Northern Ireland: what it is, how it works, the prescribing process, dosing, expected results, side effects, costs, and how to get started through an RQIA-regulated online service that delivers to your door anywhere in NI.
What Is Mounjaro?
Mounjaro is the brand name for tirzepatide, a prescription medication manufactured by Eli Lilly. It was originally developed for the treatment of type 2 diabetes but has since been licensed in the UK for weight management in adults who meet specific clinical criteria.
Mounjaro is administered as a once-weekly subcutaneous injection using a pre-filled pen device. The injection is given just under the skin, typically in the abdomen, thigh, or upper arm. The pen is designed for self-administration at home, and most patients find the process straightforward after their first use.
How Mounjaro Works: The Dual Agonist Mechanism
What sets Mounjaro apart from other weight loss medications is its dual mechanism of action. It is what scientists call a dual GIP and GLP-1 receptor agonist, meaning it activates two different hormone pathways simultaneously:
- GLP-1 (glucagon-like peptide-1): A gut hormone that reduces appetite, slows gastric emptying (so food stays in your stomach longer and you feel full for longer), and helps regulate blood sugar levels. This is the same pathway targeted by Wegovy and Ozempic.
- GIP (glucose-dependent insulinotropic polypeptide): Another gut hormone involved in appetite control, insulin secretion, and fat metabolism. By activating this additional pathway, Mounjaro appears to produce greater weight loss than medications that target GLP-1 alone.
In practical terms, patients on Mounjaro typically experience a significant reduction in hunger and food cravings. Many describe it as the internal “noise” around food being turned down. Meals become smaller, snacking decreases, and the constant preoccupation with food that many people with obesity experience begins to fade.
Mounjaro Availability in Northern Ireland
This is where things get complicated for NI patients. While Mounjaro is licensed and available in the UK, accessing it through the NHS in Northern Ireland is extremely difficult.
NHS Availability
The NHS in Northern Ireland does not widely prescribe Mounjaro for weight management at this time. While NICE has appraised tirzepatide and recognised its clinical effectiveness, the commissioning and funding of new medications in Northern Ireland operates through its own processes, which do not always align with the timelines in England. Specialist weight management services in NI, where these medications would typically be initiated, are limited in capacity and have substantial waiting lists.
In practical terms, if you go to your GP in Belfast, Derry, or anywhere else in Northern Ireland and ask for Mounjaro, you are very unlikely to receive a prescription through NHS channels at present.
The Private Prescription Route
For the majority of patients in Northern Ireland, the practical route to Mounjaro is through a private prescriber. This can be a private clinic with a physical location or an online clinic that provides remote consultations and delivers medication to your home.
The online route has become particularly popular in Northern Ireland because of the geographical challenges many NI patients face. Not everyone lives within easy reach of a private weight management clinic, and the convenience of having specialist medical care delivered remotely is significant for patients in rural areas of County Tyrone, County Fermanagh, County Armagh, and beyond.
How to Get Mounjaro Prescribed in Northern Ireland
Getting a Mounjaro prescription through Evernu is a straightforward process that can be completed entirely from home. Here is how it works, step by step:
Step 1: Complete the Medical Questionnaire
Start by completing our online medical eligibility questionnaire. This covers your medical history, current medications, weight and height (for BMI calculation), previous weight loss attempts, and any relevant health conditions. It is thorough but not onerous, and typically takes around 10 minutes.
Step 2: Clinical Assessment
Your questionnaire responses are reviewed by one of our prescribing clinicians. They assess whether Mounjaro is clinically appropriate for you based on your individual circumstances, including your BMI, medical history, and any contraindications. If additional information is needed, a clinician will contact you to discuss your case in more detail.
Step 3: Prescription and Medication Selection
If you are approved for treatment, your clinician will prescribe the appropriate starting dose of Mounjaro (typically 2.5 mg). The prescription is sent to a registered pharmacy for dispensing.
Step 4: Home Delivery
Your Mounjaro pen is delivered directly to your home anywhere in Northern Ireland. The medication is shipped in temperature-controlled packaging to maintain its integrity, as tirzepatide needs to be stored in a refrigerator (2-8 degrees Celsius) before use.
Step 5: Ongoing Monitoring and Dose Titration
Our clinical team monitors your progress throughout treatment. As you move through the titration schedule (more on this below), your dose is adjusted based on your response, tolerability, and weight loss progress.
Mounjaro Dosing Schedule
Mounjaro follows a structured dose titration schedule designed to minimise side effects and allow your body to adjust gradually. You do not start on the full therapeutic dose. Instead, you work up to it over a period of weeks:
| Dose | Duration | Purpose |
|---|---|---|
| 2.5 mg | 4 weeks | Starting dose. Allows your body to adjust. Not the therapeutic dose for weight loss. |
| 5 mg | 4 weeks | First therapeutic dose. Many patients begin to see meaningful appetite reduction and weight loss. |
| 7.5 mg | 4 weeks | Intermediate dose. Continued weight loss and appetite control. |
| 10 mg | 4 weeks | Higher therapeutic dose. Significant weight loss typically observed. |
| 12.5 mg | 4 weeks | Advanced dose for patients who tolerate well and need further weight loss. |
| 15 mg | Ongoing | Maximum dose. Not all patients need to reach this level. |
It is important to understand that not every patient needs to reach the maximum 15 mg dose. Your prescribing clinician will work with you to find the dose that provides effective weight loss with acceptable tolerability. Some patients achieve excellent results on 5 mg or 10 mg and remain on that dose long-term.
Expected Weight Loss with Mounjaro
The clinical evidence for Mounjaro’s effectiveness comes primarily from the SURMOUNT clinical trial programme, published in the New England Journal of Medicine. The headline results are striking:
- 5 mg dose: Average weight loss of approximately 15% of body weight over 72 weeks
- 10 mg dose: Average weight loss of approximately 19.5% of body weight
- 15 mg dose: Average weight loss of approximately 22.5% of body weight
To put these numbers in real-world context for Northern Ireland patients:
- A patient starting at 95 kg (just under 15 stone) on the 10 mg dose could expect to lose approximately 18.5 kg (around 2 stone 13 lbs) over the treatment period.
- A patient starting at 110 kg (17 stone 4 lbs) on the 15 mg dose could expect to lose approximately 24.75 kg (around 3 stone 13 lbs).
These are averages, meaning some patients lose more and some less. Factors that influence your individual result include your starting weight, adherence to the medication schedule, dietary changes, physical activity, sleep quality, and metabolic factors. Patients who combine Mounjaro with healthier eating habits and increased physical activity tend to achieve results at the higher end of these ranges.
When Will I Start Seeing Results?
Most patients begin to notice reduced appetite within the first one to two weeks of starting Mounjaro, even at the 2.5 mg starting dose. Visible weight loss typically becomes apparent within 4 to 8 weeks. The most significant weight loss usually occurs during the middle months of treatment (months 3 to 9) as the dose is titrated upward.
Side Effects and How to Manage Them
Like all medications, Mounjaro can cause side effects. The majority are gastrointestinal and tend to be most pronounced during the initial weeks of treatment and after each dose increase. For most patients, these effects are manageable and diminish over time.
Common Side Effects
- Nausea: The most frequently reported side effect. It is typically mild to moderate and tends to improve within 1 to 2 weeks at each dose level. Eating smaller, more frequent meals, avoiding fatty or greasy food, and staying well hydrated can help.
- Diarrhoea: Common during the first few weeks. Usually self-limiting. Staying hydrated is important.
- Constipation: Some patients experience the opposite gastrointestinal effect. Adequate fluid intake and fibre-rich foods can help.
- Decreased appetite: This is partly the intended effect of the medication, but it can feel pronounced initially. It is important to continue eating balanced meals even when appetite is reduced, to ensure adequate nutrition.
- Injection site reactions: Mild redness, itching, or discomfort at the injection site. Rotating injection sites helps minimise this.
- Fatigue: Some patients report tiredness, particularly during dose increases. This usually resolves within a few days.
Less Common but Important Side Effects
- Pancreatitis: Rare but serious. Symptoms include severe abdominal pain that may radiate to the back, with nausea and vomiting. Seek medical attention immediately if you experience these symptoms.
- Gallbladder problems: Rapid weight loss (from any cause) can increase the risk of gallstones. Report any persistent pain in the upper right abdomen to your clinician.
- Hypoglycaemia: Uncommon in patients without diabetes. More relevant for patients also taking insulin or sulphonylureas.
Our clinical team provides detailed guidance on managing side effects and is available to answer questions throughout your treatment. The gradual dose titration schedule is specifically designed to minimise side effects by giving your body time to adjust at each level before moving to the next.
Cost of Mounjaro in Northern Ireland
Since Mounjaro is almost exclusively available through private prescription in Northern Ireland, cost is an important practical consideration. Pricing varies between providers and fluctuates as wholesale medication costs change. At the time of writing, monthly costs for Mounjaro typically range from approximately:
- 2.5 mg (starter dose): From approximately £130 per month
- 5 mg: From approximately £150 per month
- 7.5 mg to 10 mg: From approximately £170 to £200 per month
- 12.5 mg to 15 mg: From approximately £200 to £260 per month
When comparing prices between providers, check what is included. At Evernu, our pricing includes the medication, clinical review, ongoing monitoring, and support. Some providers quote lower medication-only prices but charge separately for consultations and follow-up care, which can add up over time.
It is also worth noting that because you start on a lower dose and titrate up gradually, your costs are lower in the early months of treatment and increase only as your dose increases.
RQIA Regulation: Why It Matters
When you are injecting a prescription medication into your body, the quality and legitimacy of your healthcare provider is not a minor consideration. In Northern Ireland, healthcare providers are regulated by the RQIA (Regulation and Quality Improvement Authority).
Evernu is RQIA-regulated. This means our prescribing practices, clinical governance, patient safety protocols, and data handling all meet the standards required by the Northern Ireland healthcare regulator. In practical terms, this means:
- Your medical assessment is carried out by a qualified, registered prescriber
- Your prescription is legitimate and dispensed by a registered pharmacy
- Your medication is genuine and sourced through authorised pharmaceutical supply chains
- You have a clear complaints process and regulatory oversight protecting your interests
This is particularly important in the weight loss medication market, where unregulated providers and counterfeit products unfortunately exist. Choosing an RQIA-regulated service is one of the most important decisions you can make when seeking treatment in Northern Ireland.
How Mounjaro Compares to Wegovy
Mounjaro and Wegovy (semaglutide) are the two leading GLP-1 weight loss medications available in Northern Ireland. Here is how they compare:
| Feature | Mounjaro (Tirzepatide) | Wegovy (Semaglutide) |
|---|---|---|
| Mechanism | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Average weight loss (highest dose) | Up to 22.5% | Up to 15% (standard dose) |
| Administration | Once-weekly injection | Once-weekly injection |
| Cardiovascular data | Ongoing trials | Proven 20% reduction in cardiovascular events |
| Time on market | Newer | Longer track record |
Neither medication is objectively “better” for everyone. Mounjaro tends to produce greater average weight loss, while Wegovy has stronger cardiovascular evidence and a longer clinical track record. Your prescribing clinician can help you decide which is more appropriate for your individual circumstances.
For a detailed comparison, see our full guide: Wegovy vs Mounjaro.
Who Should Not Take Mounjaro
Mounjaro is not suitable for everyone. You should not take Mounjaro if you:
- Have a personal or family history of medullary thyroid carcinoma (MTC)
- Have multiple endocrine neoplasia syndrome type 2 (MEN 2)
- Have a known allergy to tirzepatide or any of the other ingredients in Mounjaro
- Are pregnant, breastfeeding, or planning to become pregnant in the near future
- Have a history of pancreatitis
- Have severe gastrointestinal disease (such as gastroparesis)
Patients with type 1 diabetes, a history of eating disorders, or those taking certain medications (particularly insulin or sulphonylureas) require careful assessment before starting treatment. Our clinical team will review all of these factors as part of your assessment.
Getting Started with Mounjaro in Northern Ireland
If you live in Northern Ireland and are considering Mounjaro for weight management, here is how to take the first step:
- Complete our eligibility questionnaire: Our free online assessment takes around 10 minutes and covers your medical history, current health, and weight loss goals.
- Clinical review: A prescribing clinician reviews your information and determines whether Mounjaro is appropriate for you.
- Start treatment: Your medication is prescribed, dispensed by a registered pharmacy, and delivered to your home anywhere in NI.
- Ongoing care: Regular monitoring, dose adjustments, and clinical support throughout your treatment.
We treat patients from across Northern Ireland, including Belfast, Derry/Londonderry, Lisburn, Newry, Bangor, Craigavon, Ballymena, Omagh, Enniskillen, and all surrounding areas. Because our service is delivered entirely online with home delivery, your location makes no difference to the quality of care you receive.
Visit our weight loss treatment page to learn more, or start your free eligibility check today.
